Ng, K., Tabernero, J., Hwang, J., Bajetta, E., Sharma, S., Del Prete, S. A., . . . Fuchs, C. S. (2013). Phase II Study of Everolimus in Patients With Metastatic Colorectal Adenocarcinoma Previously Treated With Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens.
Čikaški stil citiranjaNg, Kimmie, et al. Phase II Study of Everolimus in Patients With Metastatic Colorectal Adenocarcinoma Previously Treated With Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens. 2013.
MLA način citiranjaNg, Kimmie, et al. Phase II Study of Everolimus in Patients With Metastatic Colorectal Adenocarcinoma Previously Treated With Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens. 2013.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.